Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

In vivo data support clinical development of VX15/2503 for MS

Oct. 25, 2010

Scientists identify potential biomarkers of delirium in ICU patients

Oct. 22, 2010

DHOdehase inhibitor LAS-186323 shows favorable safety and pharmacokinetics

Oct. 22, 2010

Continued benefit seen with 4-year odanacatib therapy in postmenopausal women

Oct. 22, 2010

Phase II trials assess Amgen's antibodies in pancreatic and non-small cell lung cancer

Oct. 22, 2010

Oncolytic vaccinia virus GL-ONC1 well tolerated in patients with solid cancers

Oct. 22, 2010

Phase I trial evaluates MVA-BN PRO in castration-resistant prostate cancer

Oct. 21, 2010

ONO-4641 shows safety and tolerability in phase I trial in MS

Oct. 21, 2010

Subanalyses of CLARITY data support benefits of cladribine tablets

Oct. 21, 2010

Zealand Pharma's ZP-2307 shows bone anabolic activity in vivo

Oct. 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...